BioProTex project aims to revolutionize single-use medical textiles by replacing hazardous chemical treatments with a sustainable, bio-based solution. The solution has to capture a significant share of the fast-growing 5MEUR medical textile coating market, where new bio-based and cost-effective solutions are being feverishly sought. The project is supported by a very strong research and commercialization teams and an expert advisory board.
Currently, medical textiles rely on fossil-based polymers and multi-step finishing with toxic substances like fluorine-based compounds (such as PFAS) and heavy metals to achieve crucial water repellency and antimicrobial performance. This results in long-term waste, environmental persistence, health risks, and increased manufacturing costs due to process complexity.
BioProTex addresses these limitations by offering a patent-pending, bio-based, and biocompatible coating that delivers both antimicrobial activity and required fluid/soil resistance in a single, streamlined treatment. The coating is produced from renewable bio-based feedstocks using solvent-free and waste-free processes, making it a drop-in solution fully compatible with existing textile finishing lines (pad-dry-cure).
This treatment simplifies production, reduces chemical consumption by an estimated 30-50%, and lowers overall manufacturing costs. Crucially, BioProTex eliminates the need for fluorine and other harmful/toxic chemicals. BioProtex is a game-changer for the industry, offering a high-value alternative to non-biobased textiles while enabling the shift toward fully bio-based materials like cellulose.
A student's idea can grow into an impactful business
Support from finding potential to commercial applications.
Aalto Innovation’s services help Aalto University researchers commercialise inventions, that is, develop profitable business from research results.
